Improving access to HIV prevention for young women in Tanzania
Official title: Making women's options for HIV prevention in Tanzania accessible and joining implementation science capacity building (MWOTAJI)
Funded at Centre of Excellence in Health Monitoring and Evaluation · NIH-10930938 · Data updated 2026-11-12
This study is looking at how to make it easier for young women aged 15-24 in Tanzania to access HIV prevention methods like PrEP by creating friendly community pharmacies where they can feel comfortable getting the help they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Centre of Excellence in Health Monitoring and Evaluation NIH-funded |
| Lab location | 1 site (Morogoro, Tanzania U Rep) |
| Project start | September 18, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,245,916 |
| NIH project number | 5UG1HD113163-02 |
| Project ID | NIH-10930938 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescent girls and young women aged 15-24 living in Tanzania who are at risk of HIV infection.
✕Less likely to help
Patients outside the age range of 15-24 or those not residing in Tanzania may not benefit from this research.
What this research studies
This research focuses on enhancing the accessibility of HIV prevention methods, particularly pre-exposure prophylaxis (PrEP), for adolescent girls and young women (AGYW) aged 15-24 in Tanzania. It aims to address the barriers these young women face, such as stigma and limited awareness, by implementing a community-based pharmacy model called Malkia Klabu, which is designed to create a welcoming environment for AGYW. The study will evaluate how this model can improve the uptake of PrEP and other sexual and reproductive health services, ultimately empowering these young women to prevent HIV and unintended pregnancies.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of young women in Tanzania who access and utilize effective HIV prevention methods.
How similar studies have gone: Previous studies have shown promise in using community-based approaches to improve access to HIV prevention, indicating that this model may be effective.
Where this research is happening
-
Centre of Excellence in Health Monitoring and Evaluation
Morogoro, Tanzania U Rep Active
Researchers
- Principal investigator: Anasel, Mackfallen Giliadi — Centre of Excellence in Health Monitoring and Evaluation
- Study coordinator: Anasel, Mackfallen Giliadi
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Improving HIV Prevention and Care for Ugandan Adolescents and Young Adults
A Uganda-based research effort aims to boost HIV prevention and care outcomes for 15-24 year-olds by testing practical, community-based strategies to increase PrEP use and viral suppression.
-
Adolescent and Youth HIV Prevention and Care Improvements in Uganda
A UG1 grant is testing ways to help Ugandan teens and young adults (ages 15-24) prevent HIV and stay healthy if they have HIV, using new long-acting PrEP and community care approaches.
-
Malkia Klabu: safer, youth-friendly pharmacies to boost HIV prevention for AGYW in Tanzania
A Tanzania-based project tests a youth-friendly pharmacy model to improve access to HIV prevention and sexual health services for adolescent girls and young women.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan study tests new ways to help teens and young adults (ages 15–24) prevent HIV and stay healthy if they are living with HIV, using community-based options and long-acting PrEP.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.